|
1
|
Shadrina M, Bondarenko EA and Slominsky
PA: Genetics factors in major depression disease. Front Psychiatry.
9(334)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wangtongkum S, Sucharitakul P, Wongjaroen
S and Maneechompoo S: Prevalence of depression among a population
aged over 45 years in Chiang Mai, Thailand. J Med Assoc Thai.
91:1812–1816. 2008.PubMed/NCBI
|
|
3
|
Singkhorn O, Apidechkul T, Pitchalard K,
Moonpanane K, Hamtanon P, Sunsern R, Leaungsomnapa Y and Thepsaw J:
Prevalence of and factors associated with depression in the hill
tribe population aged 40 years and older in northern Thailand. Int
J Ment Health Syst. 15(62)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pengpid S, Peltzer K and Anantanasuwong D:
Prevalence and determinants of incident and persistent depressive
symptoms among middle-aged and older adults in Thailand:
prospective cohort study. BJPsych Open. 9(e99)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Musumari PM, Tangmunkongvorakul A,
Srithanaviboonchai K, Techasrivichien T, Suguimoto SP, Ono-Kihara M
and Kihara M: Grit is associated with lower level of depression and
anxiety among university students in Chiang Mai, Thailand: A
cross-sectional study. PLoS One. 13(e0209121)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Charoensakulchai S, Usawachoke S,
Kongbangpor W, Thanavirun P, Mitsiriswat A, Pinijnai O, Kaensingh
S, Chaiyakham N, Chamnanmont C, Ninnakala N, et al: Prevalence and
associated factors influencing depression in older adults living in
rural Thailand: A cross-sectional study. Geriatr Gerontol Int.
19:1248–1253. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Aung TNN, Moolphate S, Koyanagi Y,
Angkurawaranon C, Supakankunti S, Yuasa M and Aung MN: Depression
and associated factors among community-dwelling Thai older adults
in Northern Thailand: The relationship between history of fall and
geriatric depression. Int J Environ Res Public Health.
19(10574)2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cui L, Li S, Wang S, Wu X, Liu Y, Yu W,
Wang Y, Tang Y, Xia M and Li B: Major depressive disorder:
Hypothesis, mechanism, prevention and treatment. Signal Transduct
Target Ther. 9(30)2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Marx W, Penninx BWJH, Solmi M, Furukawa
TA, Firth J, Carvalho AF and Berk M: Major depressive disorder. Nat
Rev Dis Primers. 9(44)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Belmaker RH and Agam G: Major depressive
disorder. N Engl J Med. 358:55–68. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang X, Zhang L, Lei Y, Liu X, Zhou X, Liu
Y, Wang M, Yang L, Zhang L, Fan S and Xie P: Meta-analysis of
infectious agents and depression. Sci Rep. 4(4530)2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yu X, Wang S, Wu W, Chang H, Shan P, Yang
L, Zhang W and Wang X: Exploring new mechanism of depression from
the effects of virus on nerve cells. Cells. 12(1767)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zheng H, Webster MJ, Weickert CS, Beasley
CL, Paulus MP, Yolken RH and Savitz J: Cytomegalovirus antibodies
are associated with mood disorders, suicide, markers of
neuroinflammation, and microglia activation in postmortem brain
samples. Mol Psychiatry. 28:5282–5292. 2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Simon MS, Ioannou M, Arteaga-Henríquez G,
Wijkhuijs A, Berghmans R, Musil R, Müller N and Drexhage HA:
Premature T cell aging in major depression: A double hit by the
state of disease and cytomegalovirus infection. Brain Behav Immun
Health. 29(100608)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jones-Brando L, Dickerson F, Ford G,
Stallings C, Origoni A, Katsafanas E, Sweeney K, Squire A,
Khushalani S and Yolken R: Atypical immune response to Epstein-Barr
virus in major depressive disorder. J Affect Disord. 264:221–226.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bayturan S, Sapmaz ŞY, Uzun AD, Kandemir H
and Ecemiş T: Relationship of herpesvirus (HSV1, EBV, CMV, HHV6)
seropositivity with depressive disorder and its clinical aspects:
The first study in children. J Med Virol. 94:5484–5491.
2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sourvinos G, Morou A, Sanidas I, Codruta
I, Ezell SA, Doxaki C, Kampranis SC, Kottakis F and Tsichlis PN:
The Downregulation of GFI1 by the EZH2-NDY1/KDM2B-JARID2 Axis and
by Human Cytomegalovirus (HCMV) Associated Factors Allows the
Activation of the HCMV Major IE promoter and the transition to
productive infection. PLoS Pathog. 10(e1004136)2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kobayashi N, Oka N, Takahashi M, Shimada
K, Ishii A, Tatebayashi Y, Shigeta M, Yanagisawa H and Kondo K:
Human Herpesvirus 6B greatly increases risk of depression by
activating hypothalamic-pituitary-adrenal axis during latent phase
of infection. iScience. 23(101187)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pantry SN and Medveczky PG: Latency,
integration, and reactivation of human herpesvirus-6. Viruses.
9(194)2017.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Strenger V, Aberle SW, Nacheva EP and
Urban C: Chromosomal integration of the HHV-6 genome in a patient
with nodular sclerosis Hodgkin lymphoma. Br J Haematol.
161:594–595. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kobayashi N, Shimada K, Ishii A, Osaka R,
Nishiyama T, Shigeta M, Yanagisawa H, Oka N and Kondo K:
Identification of a strong genetic risk factor for major depressive
disorder in the human virome. iScience. 27(109203)2024.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Levey DF, Stein MB, Wendt FR, Pathak GA,
Zhou H, Aslan M, Quaden R, Harrington KM, Nuñez YZ, Overstreet C,
et al: Bi-ancestral depression GWAS in the Million Veteran Program
and meta-analysis in >1.2 million individuals highlight new
therapeutic directions. Nat Neurosci. 24:954–963. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Howard DM, Adams MJ, Clarke TK, Hafferty
JD, Gibson J, Shirali M, Coleman JRI, Hagenaars SP, Ward J, Wigmore
EM, et al: Genome-wide meta-analysis of depression identifies 102
independent variants and highlights the importance of the
prefrontal brain regions. Nat Neurosci. 22:343–352. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Flint J: The genetic basis of major
depressive disorder. Mol Psychiatry. 28:2254–2265. 2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Alshaya DS: Genetic and epigenetic factors
associated with depression: An updated overview. Saudi J Biol Sci.
29(103311)2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Fries GR, Saldana VA, Finnstein J and Rein
T: Molecular pathways of major depressive disorder converge on the
synapse. Mol Psychiatry. 28:284–297. 2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yuan M, Yang B, Rothschild G, Mann JJ,
Sanford LD, Tang X, Huang C, Wang C and Zhang W: Epigenetic
regulation in major depression and other stress-related disorders:
molecular mechanisms, clinical relevance and therapeutic potential.
Signal Transduct Target Ther. 8(309)2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ribeiro L, Busnello JV, Cantor RM, Whelan
F, Whittaker P, Deloukas P, Wong ML and Licinio J: The
brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism
and depression in Mexican-Americans. Neuroreport. 18:1291–1293.
2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nguyen VT, Hill B, Sims N, Heck A, Negron
M, Lusk C and Galindo CL: Brain-derived neurotrophic factor rs6265
(Val66Met) single nucleotide polymorphism as a master modifier of
human pathophysiology. Neural Regen Res. 18:102–106.
2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Szarowicz CA, Steece-Collier K and
Caulfield ME: New frontiers in neurodegeneration and regeneration
associated with brain-derived neurotrophic factor and the rs6265
single nucleotide polymorphism. Int J Mol Sci.
23(8011)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bieliński M, Jaracz M, Lesiewska N,
Tomaszewska M, Sikora M, Junik R, Kamińska A, Tretyn A and
Borkowska A: Association between COMT Val158Met and DAT1
polymorphisms and depressive symptoms in the obese population.
Neuropsychiatr Dis Treat. 13:2221–2229. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tonelli E, Pascale E, Troianiello M,
D'Addario C and Adriani W: DAT1 gene methylation as an epigenetic
biomarker in attention deficit hyperactivity disorder: A
commentary. Front Genet. 11(444)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Pinsonneault JK, Han DD, Burdick KE,
Kataki M, Bertolino A, Malhotra AK, Gu HH and Sadee W: Dopamine
transporter gene variant affecting expression in human brain is
associated with bipolar disorder. Neuropsychopharmacology.
36:1644–1655. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gontijo BR, Possatti I, Fratelli CF,
Pereira ASR, Bonasser LSS, de Souza Silva CM and Rodrigues da Silva
IC: The 3'UTR VNTR SLC6A3 genetic variant and major depressive
disorder: A systematic review. Biomedicines.
11(2270)2023.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Pattarachotanant N, Sritharathikhun T,
Suttirat S and Tencomnao T: Association of C/T polymorphism in
intron 14 of the dopamine transporter gene (rs40184) with major
depression in a northeastern Thai population. Genet Mol Res.
9:565–572. 2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Chen G, Liu Y, Norton N, Liu W, Zhu H,
Zhou P, Luan M, Yang S, Chen X, Carroll L, et al: Whole genome
association study in a homogenous population in Shandong peninsula
of China reveals JARID2 as a susceptibility gene for schizophrenia.
J Biomed Biotechnol. 2009(536918)2009.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Pedrosa E, Ye K, Nolan KA, Morrell L, Okun
JM, Persky AD, Saito T and Lachman HM: Positive association of
schizophrenia to JARID2 gene. Am J Med Genet B Neuropsychiatr
Genet. 144B:45–51. 2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Verberne EA, van der Laan L, Haghshenas S,
Rooney K, Levy MA, Alders M, Maas SM, Jansen S, Lieden A, Anderlid
BM, et al: DNA Methylation Signature for JARID2-Neurodevelopmental
Syndrome. Int J Mol Sci. 23(8001)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sumala S, Ekalaksananan T, Pientong C,
Buddhisa S, Passorn S, Duangjit S, Janyakhantikul S, Suktus A and
Bumrungthai S: The Association of HHV-6 and the TNF-α (-308G/A)
promotor with major depressive disorder patients and healthy
controls in Thailand. Viruses. 15(1898)2023.PubMed/NCBI View Article : Google Scholar
|
|
40
|
American Psychiatric Association: DSM-5
Task Force: Diagnostic and Statistical Manual of Mental Disorders:
DSM-5™. 5th edition. American Psychiatric Publishing, Inc.,
Washington DC, 2013.
|
|
41
|
Faris A, Hadi BH and Abidin ZS:
Development and validation of high resolution melting assays for
high-throughput screening of BDNF rs6265 and DAT1 rs40184. Malays J
Med Res. 14:2636–9346. 2018.
|
|
42
|
Chen X, Long F, Cai B, Chen X and Chen G:
A novel relationship for schizophrenia, bipolar and major
depressive disorder Part 5: A hint from chromosome 5 high density
association screen. Am J Transl Res. 9:2473–2491. 2017.PubMed/NCBI
|
|
43
|
Dochnal SA, Francois AK and Cliffe AR: De
Novo polycomb recruitment: Lessons from latent herpesviruses.
Viruses. 13(1470)2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Bergé-Lefranc JL, Jay P, Massacrier A, Cau
P, Mattei MG, Bauer S, Marsollier C, Berta P and Fontes M:
Characterization of the human jumonji gene. Hum Mol Genet.
5:1637–1641. 1996.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Haeffel GJ, Getchell M, Koposov RA,
Yrigollen CM, Deyoung CG, Klinteberg BA, Oreland L, Ruchkin VV and
Grigorenko EL: Association between polymorphisms in the dopamine
transporter gene and depression evidence for a gene-environment
interaction in a sample of juvenile detainees. Psychol Sci.
19:62–69. 2008.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Rafikova EI, Shibalev DV, Shadrina MI,
Slominsky PA, Guekht AB, Ryskov AP and Vasilyev VA: Influence of
polymorphic gene variants of the dopaminergic system on the risk of
disorders with depressive symptoms. Russ J Genet. 57:942–948.
2021.
|
|
47
|
Pizzagalli DA, Berretta S, Wooten D, Goer
F, Pilobello KT, Kumar P, Murray L, Beltzer M, Boyer-Boiteau A,
Alpert N, et al: Assessment of striatal dopamine transporter
binding in individuals with major depressive disorder: In Vivo
positron emission tomography and postmortem evidence. JAMA
Psychiatry. 76:854–861. 2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Reith MEA, Kortagere S, Wiers CE, Sun H,
Kurian MA, Galli A, Volkow ND and Lin Z: The dopamine transporter
gene SLC6A3: Multidisease risks. Mol Psychiatry. 27:1031–1046.
2022.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Lin E, Hong CJ, Hwang JP, Liou YJ, Yang
CH, Cheng D and Tsai SJ: Gene-gene interactions of the
brain-derived neurotrophic-factor and neurotrophic tyrosine kinase
receptor 2 genes in geriatric depression. Rejuvenation Res.
12:387–393. 2009.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Zhao M, Chen L, Yang J, Han D, Fang D, Qiu
X, Yang X, Qiao Z, Ma J, Wang L, et al: BDNF Val66Met polymorphism,
life stress and depression: A meta-analysis of gene-environment
interaction. J Affect Disord. 227:226–235. 2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng
JF and Yang YM: The Val66Met polymorphism of the brain-derived
neurotrophic-factor gene is associated with geriatric depression.
Neurobiol Aging. 27:1834–1837. 2006.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Porter GA and O'Connor JC: Brain-derived
neurotrophic factor and inflammation in depression: Pathogenic
partners in crime? World J Psychiatry. 12:77–97. 2022.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Hing B, Davidson S, Lear M, Breen G, Quinn
J, McGuffin P and MacKenzie A: A polymorphism associated with
depressive disorders differentially regulates brain derived
neurotrophic factor promoter IV activity. Biol Psychiatry.
71:618–626. 2012.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ropret S, Zupanc T, Komel R and Videtič
Paska A: Single nucleotide polymorphisms in the BDNF gene and
suicide in the Slovenian sample. Neurosci Lett. 602:12–16.
2015.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Egan MF, Kojima M, Callicott JH, Goldberg
TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean
M, et al: The BDNF val66met polymorphism affects activity-dependent
secretion of BDNF and human memory and hippocampal function. Cell.
112:257–269. 2003.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Bosker FJ, Hartman CA, Nolte IM, Prins BP,
Terpstra P, Posthuma D, van Veen T, Willemsen G, DeRijk RH, de Geus
EJ, et al: Poor replication of candidate genes for major depressive
disorder using genome-wide association data. Mol Psychiatry.
16:516–532. 2011.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Levinson DF, Mostafavi S, Milaneschi Y,
Rivera M, Ripke S, Wray NR and Sullivan PF: Genetic studies of
major depressive disorder: Why are there no genome-wide association
study. findings, and what can we do about it? Biol Psychiatry.
76:510–512. 2014.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Lohoff FW: Overview of the genetics of
major depressive disorder. Curr Psychiatry Rep. 12:539–546.
2010.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Li Z, Ruan M, Chen J and Fang Y: Major
Depressive Disorder: Advances in neuroscience research and
translational applications. Neurosci Bull. 37:863–880.
2021.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Roberson-Nay R, Lapato DM, Wolen AR,
Lancaster EE, Webb BT, Verhulst B, Hettema JM and York TP: An
epigenome-wide association study of early-onset major depression in
monozygotic twins. Transl Psychiatry. 10(301)2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Huider F, Milaneschi Y, van der Zee MD, de
Geus EJC, Helmer Q, Penninx BWJH and Boomsma DI: major depressive
disorder and lifestyle: Correlated genetic effects in extended twin
pedigrees. Genes (Basel). 12(1509)2021.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Sullivan PF, Neale MC and Kendler KS:
Genetic epidemiology of major depression: Review and meta-analysis.
Am J Psychiatry. 157:1552–1562. 2000.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Aref-Eshghi E, Kerkhof J and Pedro VP:
Groupe DI France. Barat-Houari M, Ruiz-Pallares N, Andrau JC,
Lacombe D, Van-Gils J, Fergelot P, et al: Evaluation of DNA
Methylation Episignatures for Diagnosis and Phenotype Correlations
in 42 Mendelian Neurodevelopmental Disorders. Am J Hum Genet.
106:356–370. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Yang H, Zhang C, Chao X, Zhao J, Liu M,
Chen J, Liu S, Wang T, Muhammad A, Schinckel AP and Zhou B: A
functional single nucleotide polymorphism in the 3' untranslated
region of the porcine JARID2 gene is associated with aggressive
behavior of weaned pigs after mixing. Int J Mol Sci.
25(27)2023.PubMed/NCBI View Article : Google Scholar
|
|
65
|
van der Laan L, Rooney K, Haghshenas S,
Silva A, McConkey H, Relator R, Levy MA, Valenzuela I, Trujillano
L, Lasa-Aranzasti A, et al: Functional insight into and refinement
of the genomic boundaries of the JARID2-Neurodevelopmental disorder
episignature. Int J Mol Sci. 24(14240)2023.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Cao R, Wang H, He J, Erdjument-Bromage H,
Tempst P and Zhang Y: Role of hPHF1 in H3K27 methylation and Hox
gene silencing. Mol Cell Biol. 28:1862–1872. 2008.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Nekrasov M, Klymenko T, Fraterman S, Papp
B, Oktaba K, Köcher T, Cohen A, Stunnenberg HG, Wilm M and Müller
J: Pcl-PRC2 is needed to generate high levels of H3-K27
trimethylation at Polycomb target genes. EMBO J. 26:4078–4088.
2007.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Herz HM and Shilatifard A: The JARID2-PRC2
duality. Genes Dev. 24:857–861. 2010.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Francois AK, Rohani A, Loftus M, Dochnal
S, Hrit J, McFarlane S, Whitford A, Lewis A, Krakowiak P, Boutell
C, et al: Single-genome analysis reveals a heterogeneous
association of the herpes simplex virus genome with H3K27me2 and
the reader PHF20L1 following infection of human fibroblasts. mBio.
15(e0327823)2024.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Bakunina N, Pariante CM and Zunszain PA:
Immune mechanisms linked to depression via oxidative stress and
neuroprogression. Immunology. 144:365–373. 2015.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Troubat R, Barone P, Leman S, Desmidt T,
Cressant A, Atanasova B, Brizard B, El Hage W, Surget A, Belzung C
and Camus V: Neuroinflammation and depression: A review. Eur J
Neurosci. 53:151–171. 2021.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Brites D and Fernandes A:
Neuroinflammation and Depression: Microglia activation,
extracellular microvesicles and microRNA dysregulation. Front Cell
Neurosci. 9(476)2015.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Peirce JM and Alviña K: The role of
inflammation and the gut microbiome in depression and anxiety. J
Neurosci Res. 97:1223–1241. 2019.PubMed/NCBI View Article : Google Scholar
|
